AV
Dr. Akash Verma
Teerthanker Mahaveer University, Indian Institute of Technology BHU, Central University of Punjab, M.J.P. Rohilkhand University
0000-0003-0043-7854
Employment
-
Teerthanker Mahaveer University Assistant Professor2024 - Present
Education
-
Indian Institute of Technology BHU PhD2019 - 2024
-
Central University of Punjab M.Pharm2017 - 2019
-
M.J.P. Rohilkhand University B.Pharm2013 - 2017
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- A highly selective pyrazole–hydrazide-based colorimetric and “turn on” fluorometric sensor for fluoride with portable device applications Save
- Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity Save
- Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy Save
- Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment Save
- Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer’s Disease with Antioxidant Potential Save
- Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer’s Disease Therapy Save
- Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer’s disease Save
- Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer’s Disease Therapy Save
- Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer’s Disease Save
- Synthesis, characterization, and biological evaluation of some novel ϒ-aminobutyric acid aminotransferase (GABA-AT) inhibitors Save